When exploring the structural components of proteins, the EGF peptide sequence stands out as a fundamental subject for researchers and enthusiasts of biochemistry. As someone who has spent significan Potential of Epidermal Growth Factor-like Peptide from the t time reviewing technical documentation and protein databases, I have found that understanding the specific architecture of this molecule is essential for grasping how it functions within various biological models.
Defining the EGF Structure
At its core, Human EGF is a 6-kDa protein with 53 amino acid residues and three critical intramolecula The structure and biosynthesis of epidermal growth factor r disulfide bonds. These bonds are vital for maintaining the structural integrity of the protein. When we discuss the EGF, epidermal growth EGF General Information factor, we are looking at a highly conserved molecule that plays a pivotal role in the epidermal growth factor family.
From my personal review of laboratory data, it is fascinating how this protein is processed. The mature EGF (53 amino acid residues) is generated through the proteolytic processing of a much larger preproprotein. In fact, the EGF is synthesized as a large protein precursor of 1,168 amino acids, which highlights the complex nature of its biosynthesis.
Technical Specifications and Sequence Analysis
For those interested in the sequence, the primary structure is well-documented. The amino acid sequence starts with a highly specific configuration: *Met-Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys*. This sequence is identical in amino acid sequence to the naturally occurring peptide found i The sequence of the first fifteen N-terminal amino acids was determined and found to beMet- Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys. Apparent Read more n many biological systems.
Key technical insights regarding the EGF gene and its products include:
* Molecular Weight: The protein is approximately 6-kDa.
* Genomic Context: The EGF gene / cDNA is a protein-c EGF Gene - Epidermal Growth Factor oding gene located on chromosome 4q25.
* Domain Structure: Structural analysis reveals the EGF chain, domains I, II, III, and IV within the receptor complex, which are critical for its interaction capacity.
* Variants: Research indicates the EGF-BP has been separated into two sequence variants, types A and B, demonstrating the diversity within this protein class.
Comparative Analysis and Variations
In my experience, comparing different forms of this peptide helps clarify its function. For instance, LONG® EGF is a specialized variant that comprises the human EGF amino acid sequence plus an additi Ribbon diagram of human EGF and EGF/EGFR complex. onal 53-amino acid N-terminal extension. This modification is frequently discussed in literature related to cell culture applications.
Furthermore, scientists often examine the EGF domain (317-355) to understand how motifs contribute to the protein's activity. Whether analyzing the EGFRp4 peptide or standard recombinant forms, the consistency of the EGF sequence remains a benchmark in structural biology.
Why Sequence Accuracy Matters
When reviewing materials, I always emphasize the importance of verified sequences. Whether you are looking at the Oligopeptide nomenclature (sometimes labeled as rh-Oligopeptide-1) or studying the Epidermal Growth Factor receptor interactions, the precision of the 53-amino acid chain is what dictates its biological efficacy.
By grounding our understanding in the human EGF is 6-kDa specification and the verified amino acid sequence, we can better by S Lundgren·1984·Cited by 42—EGF-BP has been separated into two sequence variants, types A and B, and the partial amino acid sequences suggest that both polypeptides are Read more appreciate the intricate design of this molecule. While the EGF gene provides the blueprint, the actual folding and disulfide bond formation represent the true functional state of this remarkable protein. Through careful study of these sequences, we gain a deeper appreciation for the molecular mechanisms that govern cellular signaling pathways.